United Therapeutics Corporation · NASDAQ:UTHR

Edgemond James sold 10,000 United Therapeutics Corporation shares (Form 4)

Traded May 28, 2026 · Filed May 29, 2026

On May 28, 2026, Edgemond James (CFO AND TREASURER) sold 10,000 United Therapeutics Corporation shares at an average US$565.63 for US$5.66M under a trading plan, leaving 18,876 shares. Filed May 29, 2026 (Form 4).

Sold
10,000 shares
Price
US$565.63 average (US$561.48 to US$571.48)
Value
US$5.66M
Holding after
18,876 shares
Trading plan
Yes (Made under a plan set in advance)
Role
CFO AND TREASURER

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 28, 2026Common StockOption exercise10,000US$117.7628,876Direct
May 28, 2026Common StockSale320US$561.4828,556Direct
May 28, 2026Common StockSale1,961US$562.7726,595Direct
May 28, 2026Common StockSale1,675US$563.8724,920Direct
May 28, 2026Common StockSale1,208US$564.8223,712Direct
May 28, 2026Common StockSale893US$566.0022,819Direct
May 28, 2026Common StockSale934US$566.8721,885Direct
May 28, 2026Common StockSale1,605US$567.9120,280Direct
May 28, 2026Common StockSale844US$568.9019,436Direct
May 28, 2026Common StockSale332US$570.5019,104Direct
May 28, 2026Common StockSale228US$571.4818,876Direct

Source

View original at SEC

Related